Skip to content
Open access

The relevance of modifying the vaccination strategy against Pertussis to protect infants in their first year of life

Aug 2026 · Epidemiology and Vaccinal Prevention · 0 citations · 12 references

TL;DR

To stabilize the situation, critical measures include: implementation of booster vaccination for school-aged children; mandatory maternal immunization to provide transplacental protection to newborns; and strict adherence to completion of vaccination series for children following pertussis infection.

Abstract

Relevance. Vaccination remains the most effective measure for controlling pertussis spread; however, immunization strategies may require revision in light of changing disease patterns. Aims . To identify current trends in pertussis incidence in the Russian Federation and propose modifications to vaccination strategies. Materials and methods . The study was based on analysis of statistical forms "Data on infectious and parasitic diseases" (Form No. 2) and "Data on populations of children and adults vaccinated against infectious diseases" (Form No. 6) for 2013–2025, as well as medical records of 535 infants who experienced pertussis during their first year of life in Moscow in 2023–2025. Results. Pertussis incidence in the Russian Federation demonstrates a sustained upward trend (average annual growth rate: 9.79 %), with infants under one year remaining the most vulnerable group, accompanied by an increase in pertussis-related mortality. Against this background, a substantial proportion of cases occurs among population groups most frequently serving as sources of infection for infants: during the study period, children aged 7–14 years accounted for 33–44 % of cases, while the share of adult cases increased (17 % nationally and 31 % in Moscow in 2025), substantiating the need for national implementation of age-targeted booster vaccination. The unfavorable epidemiological situation is exacerbated by delays in infant immunization (coverage < 50 % by the end of the first year of life) and low adherence to series completion among children following natural infection (among children who experienced pertussis in 2023, only 11.2 % continued immunization; in 2024 — 50.7 %; in 2025 — 7.6 %). Conclusions . To stabilize the situation, critical measures include: implementation of booster vaccination for school-aged children; mandatory maternal immunization to provide transplacental protection to newborns; and strict adherence to completion of vaccination series for children following pertussis infection.

Read PDF

Similar papers

Jul 2026

Immunity gaps for several vaccine preventable diseases in Norway.

Low IgG levels against diphtheria and tetanus both in children and in individuals over 60 years of age are demonstrated, which may be an argument for rescheduling of the DTP booster in the CIP and for including DTP vaccines in the adult vaccination program.

Audun Aase, T. Herstad, M. Greve-Isdahl et al. · 0 citations
Jul 2026

High effectiveness of infant vaccination against pertussis in 1- and 2-year-olds, the Netherlands, 2013-2024.

INTRODUCTION With still high circulation of pertussis and risk for severe disease in young children, insight into vaccine effectiveness (VE) of infant pertussis vaccination is important. In the Netherlands, NIP period 1 corresponds to the period during which the DT3aP-IPV-Hib-HBV vaccine and the 3 + 1 dose schedule wer...

D. van Meijeren, A. V. van Roon, B. de Gier et al. · 0 citations
Jul 2026

Classification of scenarios based on the determinants of childhood vaccination coverage in Brazil

Multiple socioeconomic, structural and operational factors were associated with unvaccinated rates, highlighting the relevance of healthcare service organization even in favorable social contexts and classifying municipalities into risk profiles may help guide interventions to improve coverage.

I. N. Schrarstzhaupt, F. A. Diaz-Quijano, F. Fontana Sutile Tardetti Fantinato et al. · 0 citations
Review Open access Jul 2026

Pediatric Vaccination in a Changing World. Impact on Child Health, Vaccine Hesitancy, and Future Perspectives of Immunization

Introduction: Vaccination remains one of the most effective and cost‑efficient public health interventions, dramatically reducing childhood morbidity and mortality from vaccine‑preventable diseases. However, the global immunization landscape has recently been challenged by pandemic disruptions, misinformation, inequiti...

Ferizate Dika-Haxhirexha, Ledia Qatipi, Blinera Ballanca et al. · 0 citations
Open access Jul 2026

Real-world effectiveness of maternal genetically inactivated acellular pertussis vaccination in protecting infants under three months of age: a case-control study using concurrent community-based and test-negative controls.

Maternal aPgen vaccination during pregnancy was highly likely to provide robust VE against symptomatic-PCR confirmed pertussis in infants during the first three months of life, and support the maternal pertussis vaccination with recombinant aP vaccines as effective strategy in Thailand and could be considered for other...

Farooq Phiriyasart, V. Chongsuvivatwong, Ponlagrit Kumwichar · 1 citation
Review Open access Jul 2026

Mumps Vaccination Policies and Epidemiological Consequences: A Comparative Review of the United States and Japan

Mumps remains a public health challenge worldwide despite being a vaccine-preventable disease. This review outlines the historical development and contrasting mumps vaccination policies in the United States and Japan and their epidemiological consequences. In the United States, where the two-dose measles, mumps, and ru...

Naruhito Otani, Masaki Ohmuraya, Toshiomi Okuno · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.